investor
IP News
SCROLL DOWN
IP News.
’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)
- Date
- 2021-06-10
- View
- 2841
’20 P62 LIGAND COMPOUND AND ER-PHAGY-PROMOTING USE THEREOF (KR, WO)
Provided are a composition for promoting ER-phagy, a composition for maintaining ER homeostasis or reducing ER stress, and a pharmaceutical composition for preventing and/or treating ER-stress-related diseases, which comprise a p62 ligand compound as an active ingredient.
- Prev
- ’19 NOVEL AUTOPHAGY-TARGETING CHIMERA (AUTOTAC) COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION COMPRISING SAME (KR, US, EP, JP, CN, AU,
- Next
- ’20 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES (KR, WO)